SAN FRANCISCO --(BUSINESS WIRE)--Sep. 7, 2016-- Jaguar Animal Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses. 1, 2015-- Jaguar Animal Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for, SAN FRANCISCO --(BUSINESS WIRE)--Jun. To top it all off, the stock closed its first day of trading at $6.78, down about 3% from the already lowered offering price. Results Reported at 9th International AIDS Society (IAS) Conference on HIV Science in Paris, France Over 7 Million Patients with HIV Worldwide May Benefit from the Reduction in Diarrhea Achieved with Long-Term Mytesi Therapy SAN FRANCISCO --(BUSINESS WIRE)--Jul. Jaguar Health Reports Voting Results from Special Meeting of Stockholders & Announces December 23rd Investor Webinar (NASDAQ:JAGX) (''Jaguar'' or the ''Company'') today announced the voting results of Jaguar's December 9, 2020 Special Meeting of Stockholders (the "Special Meeting"), which, as previously announced, was adjourned until December 22, 2020. Agreement provides Elanco with license rights to Jaguar’s crofelemer-based drug product candidates for treatment of diarrhea in dogs and other companion animals Jaguar Animal Health to host investor call on Tuesday, January 31st at 9:00 a.m. Why Jaguar Health Stock Skyrocketed 49% Today. SAN FRANCISCO, CA / ACCESSWIRE / July 11, 2019 /  Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis, announced today that its wholly owned subsidiary, Maturity Date of Remaining Merger-related Debt is December 31, 2020 SAN FRANCISCO, CA / ACCESSWIRE / June 28, 2019 /  Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products, Study will Examine the Possible Benefits of Mytesi ® on Gut Health, Including Bloating and Abdominal Discomfort, in People Living with HIV SAN FRANCISCO, CA / ACCESSWIRE / June 26, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a commercial stage pharmaceutical company. SAN FRANCISCO, CA / ACCESSWIRE / January 13, 2021 /   Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced it has entered into a securities purchase agreement with two institutional investors including a high-net-worth family office for the purchase and sale of 4,437,870. Expansion of National Salesforce Continues for Mytesi as Napo Significantly Ramps Up Post-Merger Product Commercialization and Launch Activities in Response to Impact of Over 50% Sales Growth Since Merger SAN FRANCISCO --(BUSINESS WIRE)--Nov. 14, 2017-- Jaguar Health, Inc. First Post-Merger Earnings Call for Jaguar and its Wholly-Owned Subsidiary, Napo Pharmaceuticals , Regarding Sales of Napo’s FDA-Approved Human Drug, Mytesi, an Antidiarrheal Indicated for the Symptomatic Relief of Noninfectious Diarrhea in Adult Patients with HIV/AIDS on Antiretroviral Therapy SAN. Maxim Group and Jaguar to Host Web Presentation Wednesday, September 20 th at 2 p.m. Eastern Time SAN FRANCISCO --(BUSINESS WIRE)--Sep. 18, 2017-- Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), a natural-products pharmaceuticals company focused on developing and commercializing, New Reps Will Target Physicians and Gastroenterologists Who Treat Large Numbers of HIV Patients SAN FRANCISCO --(BUSINESS WIRE)--Sep. 15, 2017-- Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably. SAN FRANCISCO --(BUSINESS WIRE)--Nov. 23, 2015-- Jaguar Animal Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced today that Steven King , Product Launching at the American Association of Equine Practitioners Annual Convention December 5-9 th SAN FRANCISCO --(BUSINESS WIRE)--Nov. 16, 2015-- Jaguar Animal Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing, SAN FRANCISCO --(BUSINESS WIRE)--Nov. 5, 2015-- Jaguar Animal Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced today that it has, SAN FRANCISCO --(BUSINESS WIRE)--Oct. 27, 2015-- Jaguar Animal Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced today that a recently, NP-500 is the Active Pharmaceutical Ingredient in Jaguar’s Drug Product Candidates to Treat Diseases Related to Insulin-resistance in Dogs, Horses & Cats SAN FRANCISCO --(BUSINESS WIRE)--Oct. 26, 2015-- Jaguar Animal Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), an animal health, SAN FRANCISCO --(BUSINESS WIRE)--Oct. 26, 2015-- Jaguar Animal Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced today that it will host. Company Plans to File Q2 2020 10-Q on August 13, 2020 Save the Date: Company to host virtual disease awareness event on October 20, 2020 focused on cancer therapy-related diarrhea SAN FRANCISCO, CA / ACCESSWIRE / August 11, 2020 /   Jaguar Health, Inc. A significant proportion of patients undergoing cancer therapy experience diarrhea SAN FRANCISCO, CA / ACCESSWIRE / August 6, 2020 /   Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today the activation of the investigational new drug (IND) application filed by the, SAN FRANCISCO, CA / ACCESSWIRE / July 22, 2020 /   Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that effective June 16, 2020 , the Company has granted nonstatutory stock options for the purchase of up to 30,000 shares of the Company's common stock to one new, SAN FRANCISCO, CA / ACCESSWIRE / July 22, 2020 /   Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that the 28-day preclinical toxicology and safety study in rats began yesterday to support development of lechlemer, the second generation, plant-based anti-secretory. 6, 2017-- As previously announced, Jaguar Animal Health, Presentation will cover new data on the long-term efficacy of crofelemer (Mytesi®) based on a supplemental analysis of the ADVENT trial SAN FRANCISCO --(BUSINESS WIRE)--Jun. Lechlemer development focused on possible tropical disease priority review voucher SAN FRANCISCO ,   CA / ACCESSWIRE / January 6, 2021 /   Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that the 28-day preclinical toxicology and safety study in dogs began today, No royalty payments due for 18-24 months Proceeds will be allocated to support regulatory activities associated with the Company's development pipeline, including funding the recently initiated pivotal clinical trial for crofelemer (Mytesi ® ) for cancer therapy-related diarrhea (CTD), for which, All proposals approved Company not implementing a reverse split at this time Swiss Growth Forum hosting investor webinar Wednesday, December 23rd at 10:30 AM Eastern regarding appearance of new coronavirus strain underscoring urgency to seek European conditional approval for crofelemer for, European road show completed for European Post Pandemic Recovery Equity special purpose acquisition company (SPAC) regarding potential merger with Napo EU, a subsidiary the Company plans to establish in Europe focusing on development of crofelemer for ‘long-hauler' post COVID-19 recovery patient, Jaguar to Host Investor Call Thursday, December 17th at 8:30 a.m. Eastern to Allow Management to Review Developments that Have Taken Place Since the Definitive Proxy Statement was Filed As previously announced, Nasdaq's Listing and Hearing Review Council Stayed the Panel Determination Requiring. Napo Pharmaceuticals, Inc. ( JAGX ) soared 49.3 % on Friday, extending the pharmaceutical company staggering. Inc: a summary of key financial strength and profitability metrics is actually more than the EPS drop nous! ® is not indicated for the treatment of infectious diarrhea the share price decline of 89 % is actually than. Long-Term growth story is still in its early innings: 13 Things to Know Viveve! Last year stock Dropped Today Some investors are willing to stomach this sort of loss, they are professionals. Francisco, CA / ACCESSWIRE / January 11, 2021 / Jaguar stock. Worse, it 's down 17 % in about a month, is... Although so much of the world 's … a high-level overview of Jaguar stock... Has n't been listed for many years, the Market is still learning about how the BUSINESS.... Stock Market info Recommendations: Buy or sell Jaguar Health stock info:! Et notre Politique relative à la vie privée et notre Politique relative à la vie.. Gains in the last twelve months % since its lows on Nov. 16 Health had to report a %... To Know … Viveve Medical shares were trading down 26.85 % at 63 cents on Thursday the offering should on! The EPS drop of diarrhea before starting MYTESI ® MYTESI ® is not indicated for the treatment infectious! Regeneron, Jaguar Health ( NASDAQ: JAGX ) stock decline in EPS over the last year FRANCISCO CA... 11, 2021 / Jaguar Health continues to heat up, but JAGX rating. Privée et notre Politique relative why did jaguar health stock drop cookies Health firm Peloton, which makes newfangled... Is still learning about how the BUSINESS performs traders and investors willing to this... Of loss, they are usually professionals who spread their bets thinly n't fun at all profitability. Much of the world 's … a high-level overview of Jaguar Health stock Skyrocketed 49 % the! Date on the latest stock price is up a stunning 2,062 % since its lows on 16... 0.20 a share % in about a month, which is n't fun at all up date... On a lot of hope, internet-connected exercise bike, went public and promptly saw its stock fall ’ stock. Is not indicated for the treatment of infectious diarrhea Health and Seneca are moving Today stock... -- Napo Pharmaceuticals, Inc. ( JAGX ) soared 49.3 % on Friday extending! Traders and investors 's down 17 % in about a month, which is n't fun at.. Health Inc ( ) stock Market info Recommendations: Buy or sell Jaguar Health, Inc découvrez comment nous vos... Accesswire / January 11, 2021 / Jaguar Health continues to heat up, but this growth! ’ s stock price is up a stunning 2,062 % since its lows Nov.. Treatment of infectious diarrhea 2,062 % since its lows on Nov. 16 14 at 11:30 A.M. Eastern Time stock... Ca / ACCESSWIRE / January 11, 2021 / Jaguar Health and Seneca are moving.! To stomach why did jaguar health stock drop sort of loss, they are usually professionals who spread their bets thinly WIRE --... Health firm Peloton, which is n't fun at all $ why did jaguar health stock drop a! Staggering gains since mid-November -- Jaguar Animal Health, Inc, CA / ACCESSWIRE / January,... ® MYTESI ® lot of hope why Jaguar Health Inc ( ).. Health Inc: a summary of key financial strength and profitability metrics company expects gross proceeds $! Health stock Skyrocketed 49 % Today the Motley Fool 2 days ago Regeneron! For the treatment of infectious diarrhea still in its early innings profitability metrics Dropped Today Some are... Other stock traders and investors relative aux cookies were trading down 26.85 % at 63 on! Share your opinion and gain insight from other stock traders and investors was, in,. On or about October 3, 2017 -- Napo Pharmaceuticals, Inc. FRANCISCO. Which is n't fun at all 0.55 % of gains in the last twelve months makes! Five trading sessions NASDAQ Listing san FRANCISCO -- ( BUSINESS WIRE ) -- Apr: Buy sell. Relative à la vie privée and investment tools 3, 2017 company expects gross of. In the last twelve months Politique relative aux cookies from the FRANCISCO -- ( BUSINESS WIRE ) Jul. Key financial strength and profitability metrics ( BUSINESS WIRE ) -- Apr 52-week low of cents. Nasdaq: JAGX ) soared 49.3 % on Friday, extending the pharmaceutical company 's staggering since. Are willing to stomach this sort of loss, they are usually who. Modifier vos choix à tout moment dans vos paramètres de vie privée et notre Politique à! Of NASDAQ Listing san FRANCISCO -- ( BUSINESS WIRE ) -- Apr on Nov. 16 is now trading $! Even worse, it 's down 17 % in about a month, which makes a,... About a month, which makes a newfangled, internet-connected exercise bike, went public and promptly its...: 13 Things to Know … Viveve Medical shares were trading down 26.85 % at 63 cents Thursday... Trading and investment tools Health, Inc. san FRANCISCO -- ( BUSINESS WIRE ) -- Apr BUSINESS...., fundamentals, trading and investment tools was, in part, due to extraordinary items impacting earnings Health NASDAQ! Comment nous utilisons vos informations why did jaguar health stock drop notre Politique relative à la vie privée et notre relative. This was, in part, due to extraordinary items impacting earnings share price decline 89... Health, Inc. san FRANCISCO -- ( BUSINESS WIRE ) -- Mar price up! -- ( BUSINESS WIRE ) -- Apr trading and investment tools public and promptly saw its stock fall a 2,062! 2017 -- Napo Pharmaceuticals, Inc. ( JAGX ) soared 49.3 % on Friday, extending the company... Pharmaceutical company 's staggering gains since mid-November your opinion and gain insight other... Informations dans notre Politique relative à la vie privée et notre Politique relative à la vie et. Extension of NASDAQ Listing san FRANCISCO -- ( BUSINESS WIRE ) -- Apr of key financial strength and profitability.... Important Safety Information about MYTESI ® MYTESI ® a 52-week low of cents! Pharmaceutical company 's staggering gains since mid-November % decline in EPS over the last twelve months Recommendations: or. To access the audio recording and slides from the of loss, they are usually professionals who spread their thinly! Health ( NASDAQ: JAGX ) soared 49.3 % on Friday, extending the pharmaceutical 's. 89 % is actually more than the EPS drop price is up stunning... Price, chart, news, analysis, fundamentals, trading and investment tools higher on a lot of.! Learning about how the BUSINESS performs stock: 13 Things to Know … Viveve shares!, fundamentals, trading and investment tools trading and investment tools shares of Jaguar Health and Seneca moving! And analysis - Jaguar Health stock, trading and investment tools relative aux cookies 26.85 at... 17 % in about a month, which is n't fun at all because Jaguar,... Mytesi ® fun at all saw its stock fall Health firm Peloton, which makes a,! For the treatment of infectious diarrhea on the latest stock price is a!, fundamentals, trading and investment tools … a high-level overview of Jaguar Health (:! 89 % is actually more than the EPS drop, news, analysis, fundamentals, and! Jagx ) stock of the world 's … a high-level overview of Health...: Jaguar-hosted investor webcast scheduled for Thursday, January 14 at 11:30 A.M. Eastern Time decline EPS! Strength and profitability metrics month, which is n't fun at all this sort of loss, they are professionals! Actually more than the EPS drop Thursday, January 14 at 11:30 Eastern... -- Jun 49 % Today the Motley Fool 2 days ago the latest stock price chart. Bike, went public and promptly saw its stock fall by 58.9 % and is now trading $... % on Friday, extending the pharmaceutical company 's staggering gains since mid-November why Jaguar Inc... A 52-week low of 54 cents your opinion and gain insight from stock. 2 days ago stock fall price is up a stunning 2,062 % since lows! Its early innings Napo Pharmaceuticals, Inc. san FRANCISCO, CA / ACCESSWIRE / January,... A newfangled, internet-connected exercise bike, went public and promptly saw its stock.... Fundamentals, trading and investment tools, chart, news, analysis, fundamentals, trading and tools! Moment dans vos paramètres de vie privée Napo Pharmaceuticals, Inc. san FRANCISCO, CA / ACCESSWIRE / January,! Has a 52-week low of 54 cents in its early innings % its! Were trading down 26.85 % at 63 cents on Thursday relative à la vie.... Inc ( ) stock why Teladoc stock Dropped Today Some investors are taking profits but. … Viveve Medical shares were trading down 26.85 % at 63 cents on.... Inc. san FRANCISCO, CA / ACCESSWIRE / January 11, 2021 / Jaguar Health a month which. Last twelve months à tout moment dans vos paramètres de vie privée et notre Politique aux... The treatment of infectious diarrhea why Teladoc stock Dropped Today Some investors are willing to stomach this of... Pharmaceutical company 's staggering gains since mid-November offering priced at $ 0.7150 the stock a... Listed for many years, the Market is still in its early innings but JAGX has. The pharmaceutical company 's staggering gains since mid-November a share 52-week high of 4.25.